Feedback
Settings

Settings

Goto Application

1. WO2002002109 - USE OF GALIELLA LACTONE

PermaLink
Publication Number WO/2002/002109
Publication Date 10.01.2002
International Application No. PCT/EP2001/006935
International Filing Date 20.06.2001
Chapter 2 Demand Filed 08.01.2002
IPC
A61K 31/365 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
365Lactones
C07D 307/93 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
307Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
77ortho- or peri-condensed with carbocyclic rings or ring systems
93condensed with a ring other than six-membered
CPC
A61K 31/365
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
365Lactones
A61P 1/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
04for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
A61P 1/16
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
16for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
A61P 25/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
02for peripheral neuropathies
A61P 25/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
04Centrally acting analgesics, e.g. opioids
A61P 25/18
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Applicants
  • INSTITUT FÜR BIOTECHNOLOGIE UND WIRKSTOFF-FORSCHUNG E.V. [DE]/[DE] (AllExceptUS)
  • BAUMGARTEN, Jörg [DE]/[DE] (UsOnly)
  • WEIDLER, Marcus [DE]/[DE] (UsOnly)
  • ERKEL, Gerhard [DE]/[DE] (UsOnly)
  • ANKE, Heidrun [DE]/[DE] (UsOnly)
  • ANKE, Timm [DE]/[DE] (UsOnly)
Inventors
  • BAUMGARTEN, Jörg
  • WEIDLER, Marcus
  • ERKEL, Gerhard
  • ANKE, Heidrun
  • ANKE, Timm
Agents
  • NOBBE, Matthias
Priority Data
100 32 242.503.07.2000DE
100 47 295.825.09.2000DE
Publication Language German (DE)
Filing Language German (DE)
Designated States
Title
(DE) VERWENDUNG VON GALIELLA-LACTON
(EN) USE OF GALIELLA LACTONE
(FR) UTILISATION DE LACTONE DE GALIELLE
front page image
Abstract
(DE)
Die Erfindung betrifft die Verwendung der unter dem Namen Galiella-Lacton bekannten Substanz als Arzneimittel, insbesondere zur Behandlung von entzündlichen Prozessen.
(EN)
The invention relates to the use of the substance known as galiella lactone as a pharmaceutical, especially for treating inflammatory processes.
(FR)
L'invention concerne l'utilisation de la substance connue sous le nom de lactone de galielle comme médicament, en particulier pour le traitement de processus inflammatoires.
Also published as
EP1408959
CA2414660
AU2001272490
JP2004501970
US6512007
Latest bibliographic data on file with the International Bureau
# -